Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

14.990
-0.710-4.52%
Volume:34.51M
Turnover:528.98M
Market Cap:37.77B
PE:3.73
High:16.260
Open:15.900
Low:14.930
Close:15.700
52wk High:34.905
52wk Low:14.594
Shares:2.52B
HK Float Shares:2.52B
Volume Ratio:2.68
T/O Rate:1.37%
Dividend:0.25
Dividend Rate:1.68%
EPS(LYR):4.015
ROE:35.88%
ROA:22.68%
PB:1.17
PE(LYR):3.73
PS:1.81

Loading ...

3SBio (01530) Calls 25 Jun 2026 AGM; Seeks 20% Share-Issue Mandate, 10% Buy-Back Power, HK$0.25 Final Dividend and Auditor Shift to KPMG

Bulletin Express
·
Jun 03

3SBio announces annual general meeting

Reuters
·
Jun 03

Stock Track | 3SBIO Plummets 7.40% Intraday as Biotech Sector Sees Profit-Taking After ASCO Catalyst Run-Up

Stock Track
·
Jun 02

Movement Alert|3SBio Falls 5.62% in Regular Trading, Biotech Sector Pulls Back After ASCO Catalyst

Market Focus
·
Jun 02

Stock Track | 3SBIO Soars 6.00% at Market Open on Positive ASCO Clinical Data and Pfizer Licensing Deal

Stock Track
·
Jun 01

Movement Alert|3SBio Rises 8% in Regular Trading, ASCO Annual Meeting SSGJ-707 Clinical Data Continues to Drive Momentum

Market Focus
·
Jun 01

Movement Alert|3SBio Rises 5.95% at Open, ASCO Clinical Data for SSGJ-707 Continues to Drive Momentum

Market Focus
·
Jun 01

Stock Track | 3SBio Soars 5.10% Intraday on Positive Clinical Data Presentation at ASCO Annual Meeting

Stock Track
·
May 29

Movement Alert|3SBio Rises 5.1% in Regular Trading, SSGJ-707 Clinical Data Showcased at ASCO Annual Meeting

Market Focus
·
May 29

Stock Track | 3SBIO Plummets 5.09% Intraday on Subsidiary IPO Expiration and Auditor Change

Stock Track
·
May 28

Movement Alert|3SBio Falls 5.25% in Regular Trading, Subsidiary IPO Expiration and Auditor Change Weigh on Sentiment

Market Focus
·
May 28

3SBIO to Appoint KPMG as New Auditor

Stock News
·
May 26

3SBio proposes KPMG as new auditor, replacing EY after 15 years

Reuters
·
May 26

Stock Track | 3SBIO Plummets 5.56% Intraday as Subsidiary Mandi International's IPO Application Expires

Stock Track
·
May 26

Movement Alert|3SBio Falls 5.51% in Regular Trading, Subsidiary Mandi International IPO Application Expires

Market Focus
·
May 26

Zhongtai Securities Maintains "Buy" on 3SBIO, Citing Unlocked Market Value Potential

Deep News
·
May 17

Zhongtai Securities Reiterates "Buy" Rating on 3SBIO (01530), Citing Early-Stage Pipeline with Multiple Potential First-in-Class Candidates for US-China Dual Submissions

Stock News
·
May 15

3SBIO Maintains "Buy" Rating from China Post Securities as Global Value Accelerates Through Multiple Clinical Trials

Stock News
·
May 12

3SBio Adds 34,000 Shares in April After Option Exercises, Keeps Public Float Above 25%

Bulletin Express
·
May 06

Stock Track | 3SBIO Soars 6.03% Intraday as SSS68 Injection Receives IND Approval for Three Indications

Stock Track
·
Apr 30